Company Profile
Sansum Diabetes Research Institute
Company Overview
Located in Santa Barbara, CA, Sansum Diabetes Research Institute (SDRI) is a non-profit organization and center of excellence with a mission to improve the lives of people impacted by diabetes through research, education, and clinical care.
Industry-Preferred Partner: SDRI is a preferred site for clinical trials, a testament to our exceptional research capabilities and commitment to advancing diabetes care. On average, SDRI conducts 25+ research studies annually engaging approximately 750 subjects each year. Current industry partners include Abbott, Dexcom, Insulet, Lilly, Mannkind, Medtronic Diabetes, Novo Nordisk, Sanofi, and Tandem Diabetes Care.
Unparalleled Expertise: SDRI has a robust team of 25 full-time and 17 part-time staff members who are highly respected for their ethical practices, accelerated recruitment efforts, and rigorous safety measures. With low turnover and high retention, SDRI ensures stability and continuity in clinical research.
Trusted Reputation: SDRI has earned the highest ratings from independent charity evaluators, Candid and Charity Navigator, reflecting our dedication to upholding the highest standards of integrity, efficiency, and transparency in all aspects of our work.
Company History
Innovative Research.
Inspiring Hope.
SDRI proudly celebrated the 100th anniversary of our founder, Dr. Sansum being the first U.S. physician to manufacture and administer insulin in the treatment of diabetes.
Dr. Sansum was driven to develop the hormone made by pancreatic secretions missing in those living with type 1 diabetes. In 1922, Dr. Sansum administered the first dose of insulin to Charles Cowan, a terminally ill farmer battling diabetes. Due to this critical medical intervention, Cowan lived to be 90 years old.
When news spread of Dr. Sansum’s discovery, patients from all over the country flocked to Santa Barbara seeking his lifegiving insulin. This ultimately led Dr. Sansum to establish Sansum Diabetes Research Institute in 1944 to further groundbreaking work in diabetes research.
In the following decades, SDRI continued to push the boundaries of diabetes research, education and care transforming the lives of patients worldwide. In the 1980s, the late Dr. Lois Jovanovic, former Chief Scientific Officer and Chief Executive Officer at SDRI, revolutionized diabetes treatment during pregnancy with her pioneering research and treatment guidelines.
By the 2000s, physician investigators made seminal contributions to the development of the artificial pancreas, a medical device that revolutionized diabetes management by continuously monitoring blood sugar levels and delivering precise doses of insulin to maintain glucose control.
Today, the heart of SDRI’s mission has remained unchanged: to advance critical research initiatives to improve the health and quality of life for the millions of individuals who live with any form of diabetes.
Benefits
Competitive Salaries: Attractive compensation aligned with industry standards.
Ongoing Training and Development: Access to programs that promote continuous learning and opportunities for career advancement.
Health Insurance: 100% employer-paid premiums for the employee's medical (Anthem PPO plan), dental, vision, life, and long-term disability insurance plans.
Dependent Coverage Support: An additional $300 per month towards dependent medical insurance premiums.
Supplemental Benefits: Opportunities to purchase supplemental life and critical care insurance at a reduced cost.
Retirement Plan: A 403(b) retirement plan with a discretionary employer match to help secure your financial future.
Generous Paid Time Off: Enjoy 15 vacation days, 11 paid holidays, and 2 floating holidays each year.
Inclusive Work Environment: Be part of a collaborative workplace that values diversity and inclusion.
Positions Available
- Viewing 1 - 1 of 1 Jobs